Literature DB >> 7820799

Availability of thrombolytic therapy in rural Newfoundland and Labrador.

S Marshall1, M Godwin, R Miller.   

Abstract

OBJECTIVE: To determine the availability of thrombolytic therapy in rural Newfoundland and Labrador.
DESIGN: Self-administered questionnaire mailed to staff at health care facilities. Respondents were sent two reminders by mail, and questionnaires not returned were completed through telephone interviews.
SETTING: Rural health care facilities, including hospitals, 24-hour clinics and satellite clinics. PARTICIPANTS: All chief medical officers, nursing supervisors and administrators in the 34 government-funded rural health care facilities in Newfoundland and Labrador. OUTCOME MEASURES: Number of facilities offering thrombolytic therapy to patients with acute myocardial infarction (AMI) in 1992. For each facility: number of patients presenting with AMI during that year, number of these patients who received thrombolytic therapy, number of staff trained in advanced cardiac life support, travel time to the nearest referral centre, population served and number of beds.
RESULTS: Of the 34 rural health care facilities in Newfoundland and Labrador, 91% (31/34) responded to the survey. Thrombolytic therapy was offered in 93% (13/14) of the rural hospitals, 22% (2/9) of the 24-hour clinics and none of the single-physician satellite clinics. In 1992, 390 patients with AMI presented to these health care facilities; 39% of these patients presented to facilities that did not offer thrombolytic therapy.
CONCLUSIONS: Thrombolytic therapy has been successfully introduced in many of the rural and isolated health care facilities in Newfoundland and Labrador. An important factor in this success is continuing medical and nursing education on the effectiveness of thrombolytic therapy and the skills needed to provide it. Cost-effectiveness data are needed to determine whether it is reasonable to offer this therapy in isolated, low-volume clinics. More research on the outcomes in patients receiving thrombolytic therapy in rural facilities is also needed.

Entities:  

Mesh:

Year:  1995        PMID: 7820799      PMCID: PMC1337572     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

Review 1.  Comparative safety of thrombolytic agents.

Authors:  H D White
Journal:  Am J Cardiol       Date:  1991-12-05       Impact factor: 2.778

2.  Intravenous streptokinase for treatment of acute myocardial infarction in small hospitals.

Authors:  R Henry; F deGruy
Journal:  J Fam Pract       Date:  1988-04       Impact factor: 0.493

3.  Comparison of thrombolytic therapy for acute myocardial infarction in rural and urban settings.

Authors:  C A McNamara; M W Burket; P S Brewster; R F Leighton; T D Fraker
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

4.  What proportion of patients with myocardial infarction are suitable for thrombolysis?

Authors:  N Murray; J Lyons; C Layton; R Balcon
Journal:  Br Heart J       Date:  1987-02

Review 5.  Selection of patients with acute myocardial infarction for thrombolytic therapy.

Authors:  D W Muller; E J Topol
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

Review 6.  Thrombolytic therapy in acute MI. Weighing the risks and benefits.

Authors:  K G Ro; H V Anderson
Journal:  Postgrad Med       Date:  1990-12       Impact factor: 3.840

7.  Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction .

Authors:  A S Midgette; G T O'Connor; J A Baron; J Bell
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

8.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; M Takayama; A Maslowski; N M Bass; J A Ormiston; T Whitlock
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

9.  The use of intravenous streptokinase in a rural community hospital.

Authors:  J J Epplin; R A Wujek; L D Laughlin
Journal:  J Am Board Fam Pract       Date:  1988 Apr-Jun

10.  The primary care physician and thrombolytic therapy for acute myocardial infarction: comparison of intravenous streptokinase in community hospitals and the tertiary referral center.

Authors:  G J Taylor; A Song; H W Moses; D L Koester; F L Mikell; J T Dove; R E Katholi; H A Wellons; J A Schneider
Journal:  J Am Board Fam Pract       Date:  1990 Jan-Mar
View more
  1 in total

Review 1.  Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics.

Authors:  S Barton; T Walley
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.